Neoglaucit
Category
Neoglaucit Brand names, Neoglaucit Analogs
Neoglaucit Brand Names Mixture
Neoglaucit Chemical_Formula
C6H14FO3P
Neoglaucit RX_link
No information avaliable
Neoglaucit fda sheet
Neoglaucit msds (material safety sheet)
Neoglaucit Synthesis Reference
No information avaliable
Neoglaucit Molecular Weight
184.146 g/mol
Neoglaucit Melting Point
-82 oC
Neoglaucit H2O Solubility
1.54E+004 mg/L
Neoglaucit State
Liquid
Neoglaucit LogP
1.13
Neoglaucit Dosage Forms
No information avaliable
Neoglaucit Indication
For use in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia.
Neoglaucit Pharmacology
Isoflurophate is used as ocular drops in the treatment of chronic glaucoma. Isoflurophate is an organophosphorus compound that acts as an irreversible cholinesterase inhibitor. As such, it displays parasympathomimetic effects. Isoflurophate is used in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia. They may also be used in the diagnosis of certain eye conditions, such as accommodative esotropia. Isoflurophate damages the acetylcholinesterase enzyme and is therefore irreversible, however, pralidoxime can displace organophosphates such as isoflurophate from acetylcholinesterase, but only if administered before isoflurophate damages (alkylates) the enzyme.
Neoglaucit Absorption
No information avaliable
Neoglaucit side effects and Toxicity
Signs of overdose include increased sweating, loss of bladder control, muscle weakness, nausea, vomiting, diarrhea, or stomach cramps or pain, shortness of breath, tightness in chest, or wheezing, slow or irregular heartbeat, unusual tiredness or weakness, watering of mouth.
Neoglaucit Patient Information
No information avaliable
Neoglaucit Organisms Affected
Humans and other mammals
